Ribavirin API Manufacturers

Looking for Ribavirin API 36791-04-5?

Description:

Here you will find a list of producers, manufacturers and distributors of Ribavirin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Ribavirin 

Synonyms:

RBV , Ribavirin , Ribavirina , Ribavirine , Ribavirinum , Tribavirin  

Cas Number:

36791-04-5 

DrugBank number:

DB00811 

Unique Ingredient Identifier:

49717AWG6K

Ribavirin is a type of Anti-HCV agents

Anti-HCV agents, belonging to the pharmaceutical API category, are potent medications used in the treatment of Hepatitis C Virus (HCV) infection. Hepatitis C is a viral disease that affects the liver and can lead to severe health complications if left untreated. Anti-HCV agents work by targeting specific mechanisms involved in the replication and spread of the HCV virus within the body.

These pharmaceutical APIs are designed to inhibit various steps of the viral lifecycle, including viral entry into liver cells, viral RNA replication, and assembly of new viral particles. By disrupting these critical processes, anti-HCV agents effectively reduce the viral load in the body, slow down disease progression, and ultimately improve patient outcomes.

The development of anti-HCV agents has revolutionized the management of HCV infection, offering new hope for patients. These APIs are often used in combination with other antiviral drugs to form highly effective treatment regimens known as direct-acting antiviral (DAA) therapies. DAAs have significantly higher cure rates compared to older treatment options, such as interferon-based therapies, and are associated with fewer side effects.

The pharmaceutical industry has made significant advancements in the development of anti-HCV agents, resulting in a diverse range of APIs with varying mechanisms of action. This diversity allows healthcare professionals to tailor treatment plans based on the specific characteristics of each patient's HCV infection, maximizing the chances of successful viral eradication.

In summary, anti-HCV agents are a crucial category of pharmaceutical APIs used in the treatment of Hepatitis C. Their targeted action against the HCV virus has revolutionized the management of this chronic infection, providing more effective and better-tolerated treatment options for patients.

• LGM Pharma from United States, product country of origin World
• Yamasa Corp. from Japan, product country of origin Japan
• Star Lake Bioscience from China, product country of origin China
• Yuhan Chemical from South Korea, product country of origin South Korea
• Jinan Mingxin from China, product country of origin China
• Zhejiang Chengyi from China, product country of origin China
• Euticals from Italy, product country of origin Unknown
• Bidachem from Italy, product country of origin Italy
• Siegfried from Germany, product country of origin Unknown
• Shaoxing Hantai Pharma from China, product country of origin China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.